Northland Capmk Forecasts Arteris’ Q1 Earnings (NASDAQ:AIP)

Arteris, Inc. (NASDAQ:AIP) – Equities researchers at Northland Capmk cut their Q1 2025 earnings per share (EPS) estimates for Arteris in a research note issued to investors on Wednesday, February 19th. Northland Capmk analyst G. Richard now forecasts that the company will earn ($0.21) per share for the quarter, down from their previous forecast of ($0.17). The consensus estimate for Arteris’ current full-year earnings is ($0.73) per share. Northland Capmk also issued estimates for Arteris’ Q2 2025 earnings at ($0.19) EPS, Q3 2025 earnings at ($0.17) EPS, Q4 2025 earnings at ($0.15) EPS, FY2025 earnings at ($0.71) EPS and FY2026 earnings at ($0.42) EPS.

Other equities research analysts have also issued reports about the company. Northland Securities increased their price target on Arteris from $14.00 to $16.00 and gave the company an “outperform” rating in a research report on Wednesday, February 19th. Rosenblatt Securities restated a “buy” rating and issued a $15.00 price objective on shares of Arteris in a research note on Tuesday, February 18th.

Arteris Trading Down 4.6 %

NASDAQ AIP opened at $8.89 on Monday. The firm has a market capitalization of $364.05 million, a P/E ratio of -10.22 and a beta of 1.18. The business has a fifty day simple moving average of $10.50 and a 200 day simple moving average of $8.78. Arteris has a 12 month low of $5.76 and a 12 month high of $12.64. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.30.

Arteris (NASDAQ:AIP) last issued its earnings results on Tuesday, February 18th. The company reported ($0.19) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.08). Arteris had a negative return on equity of 828.71% and a negative net margin of 58.27%. The firm had revenue of $15.49 million for the quarter, compared to analyst estimates of $15.34 million.

Insider Buying and Selling

In related news, VP Paul L. Alpern sold 2,471 shares of the stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $11.41, for a total transaction of $28,194.11. Following the sale, the vice president now owns 64,930 shares of the company’s stock, valued at approximately $740,851.30. This represents a 3.67 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Nicholas B. Hawkins sold 11,000 shares of the firm’s stock in a transaction dated Monday, February 3rd. The shares were sold at an average price of $10.33, for a total value of $113,630.00. Following the completion of the sale, the chief financial officer now directly owns 154,308 shares in the company, valued at approximately $1,594,001.64. The trade was a 6.65 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 367,157 shares of company stock valued at $3,828,388. Corporate insiders own 33.70% of the company’s stock.

Hedge Funds Weigh In On Arteris

Large investors have recently modified their holdings of the company. State Street Corp raised its holdings in shares of Arteris by 18.5% during the 3rd quarter. State Street Corp now owns 410,578 shares of the company’s stock valued at $3,170,000 after buying an additional 64,081 shares in the last quarter. JPMorgan Chase & Co. boosted its position in shares of Arteris by 67.1% during the third quarter. JPMorgan Chase & Co. now owns 92,242 shares of the company’s stock valued at $712,000 after purchasing an additional 37,032 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Arteris by 6.6% during the third quarter. Geode Capital Management LLC now owns 597,116 shares of the company’s stock valued at $4,610,000 after purchasing an additional 36,908 shares in the last quarter. Barclays PLC boosted its position in shares of Arteris by 321.1% during the third quarter. Barclays PLC now owns 39,396 shares of the company’s stock valued at $304,000 after purchasing an additional 30,041 shares in the last quarter. Finally, Dynamic Technology Lab Private Ltd bought a new stake in shares of Arteris during the third quarter valued at approximately $226,000. 64.36% of the stock is owned by hedge funds and other institutional investors.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.